C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/435 (2006.01) A61K 38/22 (2006.01)
Patent
CA 2577010
The present invention encompasses PEGylated peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
La présente invention a pour objet des peptides PEGylés qui activent de façon sélective le récepteur VPAC2 et peuvent être employés dans le traitement de diabètes.
Alsina-Fernandez Jorge
Bokvist Bengt Krister
Mayer John Philip
Vick Andrew Mark
Zhang Lianshan
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Selective vpac2 receptor peptide agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective vpac2 receptor peptide agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective vpac2 receptor peptide agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1785352